Document is current
Any future updates will be listed below
-
Authors
Aftabizadeh, Maryam
Blanchard, Marie Suzette
Stiller, Tracey
Natri, Heini M
Aguilar, Brenda
Wagner, Jamie R
Paul, Jinny A
Starr, Renate
Ressler, Julie A
Kilpatrick, Julie
Myers-McNamara, Paige
D’Apuzzo, Massimo
Benovich, Nicholas
Forman, Stephen J
Barish, Michael E
Badie, Behnam
Brown, Christine E
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04214392 at ClinicalTrials.govnct04214392 at ClinicalTrials.govDocuments that mention this clinical trial
221 Single-cell characterization of novel chlorotoxin-directed CAR T cells for the treatment of patients with MMP2+ glioblastoma
https://doi.org/10.1136/jitc-2025-sitc2025.0221
Highlights in IO: next-generation CAR-T therapy for glioblastoma
https://doi.org/10.1136/jitc-2025-014670
1525 Initial clinical experience with chlorotoxin-redirected CAR T cells for patients with recurrent glioblastoma
https://doi.org/10.1136/jitc-2023-sitc2023.1525
Documents that mention this clinical trial
221 Single-cell characterization of novel chlorotoxin-directed CAR T cells for the treatment of patients with MMP2+ glioblastoma
https://doi.org/10.1136/jitc-2025-sitc2025.0221
Highlights in IO: next-generation CAR-T therapy for glioblastoma
https://doi.org/10.1136/jitc-2025-014670
1525 Initial clinical experience with chlorotoxin-redirected CAR T cells for patients with recurrent glioblastoma
https://doi.org/10.1136/jitc-2023-sitc2023.1525
- License Information
